PA8552001A1 - 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS - Google Patents
1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOSInfo
- Publication number
- PA8552001A1 PA8552001A1 PA8552001A PA8552001A PA8552001A1 PA 8552001 A1 PA8552001 A1 PA 8552001A1 PA 8552001 A PA8552001 A PA 8552001A PA 8552001 A PA8552001 A PA 8552001A PA 8552001 A1 PA8552001 A1 PA 8552001A1
- Authority
- PA
- Panama
- Prior art keywords
- hypertension
- rent
- angina
- diabetes
- description
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title 1
- 206010002383 Angina Pectoris Diseases 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 abstract 2
- KKJUPNGICOCCDW-UHFFFAOYSA-N 7-N,N-Dimethylamino-1,2,3,4,5-pentathiocyclooctane Chemical compound CN(C)C1CSSSSSC1 KKJUPNGICOCCDW-UHFFFAOYSA-N 0.000 abstract 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010048554 Endothelial dysfunction Diseases 0.000 abstract 1
- 208000010228 Erectile Dysfunction Diseases 0.000 abstract 1
- 208000007530 Essential hypertension Diseases 0.000 abstract 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 201000003099 Renovascular Hypertension Diseases 0.000 abstract 1
- 201000004239 Secondary hypertension Diseases 0.000 abstract 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000033115 angiogenesis Effects 0.000 abstract 1
- 210000001367 artery Anatomy 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 208000020832 chronic kidney disease Diseases 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000008694 endothelial dysfunction Effects 0.000 abstract 1
- 230000003511 endothelial effect Effects 0.000 abstract 1
- 230000002440 hepatic effect Effects 0.000 abstract 1
- 201000001881 impotence Diseases 0.000 abstract 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
- 208000017169 kidney disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 208000002815 pulmonary hypertension Diseases 0.000 abstract 1
- 208000037803 restenosis Diseases 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE FORMULA (1), DONDE R1-R4 TIENEN LOS MISMOS SIGNIFICADOS DADOS EN LA DESCRIPCION, A ES CH2, CHOH O CH-(ALQUILO C1-C3),B Y C SON, INDEPENDIENTEMENTE, CH2 O CH-(ALQUILO C1-C3), Y R5 ES UN GRUPO ARILO O HETEROARILO, OPCIONALMENTE SUSTITUIDO CON LOS SUSTITUYENTES ENUMERADOS EN LA DESCRIPCION. ESTOS COMPUESTOS SON UTILES PARA LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES, ANGINA DE PECHO ESTABLE E INESTABLE, CARDIOPATIA CORONARIA, ANGINA DE PRINZMETAL, SINDROME AGUDO DE LAS CORONARIAS, INSUFICI3ENCIA CARDIACA, INFARTO DE MIOCARDIO, ATAQUE DE APOPLEJIA, TROMBOSIS, ENFERMEDAD OCLUSIVA DE LAS ARTERIAS PERIFERICAS, DISFUNCION ENDOTELIAL, ATEROSCLEROSIS, RESTENOSIS, DAÑO ENDOTELIAL DESPUES DE PTCA, HIPERTENSION, HIPERTENSION ESENCIAL, HIPERTENSION PULMONAR, HIPERTENSION SECUNDARIA, HIPERTENSION RENOVASCULAR, GLOMERULONEFRITIS CRONICA, DISFUNCION ERECTIL, ARRITMIA VENTRICULAR, DIABETES, COMPLICACIONES DE LA DIABETES, NEFROPATIA, RETINOPATIA, ANGIOGENESIS, ASMA BRONQUIAL, INSUFICIENCIA RENAL CRONICA, CIRROSIS HEPATICA, OSTEOROPOROSIS, O FUNCIONAMIENTO LIMITADO DE LA MEMORIA O CAPACIDAD DE APRENDIZAJE LIMITADA, O DISMINUCION DEL RIESGO CARDIOVASCULAR DE LAS MUJERES MENOPAUSICAS O DESPUES DE INGERIR CONTRACEPTIVOS.THIS INVENTION REFERS TO FORMULA COMPOUNDS (1), WHERE R1-R4 HAS THE SAME MEANINGS GIVEN IN THE DESCRIPTION, A IS CH2, CHOH OR CH- (C1-C3 RENT), BYC SON, INDEPENDENTLY, CH2 OR CH- (RENT C1-C3), AND R5 IS AN ARILO OR HETEROARILO GROUP, OPTIONALLY REPLACED WITH THE SUBSTITUTES LISTED IN THE DESCRIPTION. THESE COMPOUNDS ARE USEFUL FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, ANGINA OF STABLE AND UNSTABLE CHEST, CORONARY CARDIOPATIA, ANGINA DE PRINZMETAL, ACUTE SYMPOSIUM OF CORONARY DISEASE, CARDIIOUSNESS, BODY CARDIOBILITY, CARDIOPATHY ADDITIONALITY occlusive ARTERY peripheral endothelial dysfunction, atherosclerosis, restenosis, DAMAGE ENDOTHELIAL after PTCA, hypertension, essential hypertension, hypertension PULMONARY hYPERTENSION SECONDARY, renovascular hypertension, chronic glomerulonephritis, erectile dysfunction, ventricular arrhythmia, diabetes, complications of diabetes, nephropathy , RETINOPATIA, ANGIOGENESIS, BRONCHIAL ASTHMA, CHRONIC RENAL INSUFFICIENCY, HEPATIC CIRROSIS, OSTEOROPOROSIS, OR LIMITED FUNCTIONING OF THE MEMORY OR LIMITED LEARNING CAPACITY, OR DECREASE OF THE CARDIOVASCULAR RISK UNDER THE WRONG OPENING OF THE WOMEN.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PA8552001A PA8552001A1 (en) | 2002-08-06 | 2002-08-06 | 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PA8552001A PA8552001A1 (en) | 2002-08-06 | 2002-08-06 | 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PA8552001A1 true PA8552001A1 (en) | 2004-02-16 |
Family
ID=40257236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PA8552001A PA8552001A1 (en) | 2002-08-06 | 2002-08-06 | 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS |
Country Status (1)
| Country | Link |
|---|---|
| PA (1) | PA8552001A1 (en) |
-
2002
- 2002-08-06 PA PA8552001A patent/PA8552001A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2006000883A (en) | INDANIL ACILATED AMINAS AND ITS USE AS PHARMACOS | |
| UY27164A1 (en) | 1, 2, 3, 4- TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS | |
| PE20020884A1 (en) | 4-FLUORO-N-INDAN-2-IL-BENZAMIDE AND ITS USE AS A PHARMACEUTICAL PRODUCT | |
| MXPA03006893A (en) | Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical. | |
| PE20220425A1 (en) | 3-AMINO-4H-BENZO[E][1,2,4]THIADIAZINE 1,1-DIOXIDE DERIVATIVES AS MRGX2 INHIBITORS | |
| DOP2006000210A (en) | AMIDA PYRIMIDINE COMPOUNDS AS PGDS INHIBITORS | |
| NO20076502L (en) | Pyrrolopyridines useful as inhibitors of protein kinase | |
| CL2012000981A1 (en) | Compounds derived from 5-ethynyl-2 - [(3-phenyl-1h-pyrazolo [3.4-d] pyrimidin-1-yl) methyl] quinazolin-4 (3h) -one, phosphoinositide 3-kinase inhibitors intermediate compounds; without pharmacological action; pharmaceutical composition; Useful in the treatment of COPD, asthma, cystic and pulmonary fibrosis, sarcoidosis, among others. | |
| CY1108744T1 (en) | 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine-3-yl-piperidines as CGRP antagonists | |
| DK1532269T3 (en) | 1L1RL-1 as a marker of cardiovascular disease | |
| CY1113792T1 (en) | PHARMACEUTICAL COMPOSITIONS OF CONTROLLED FREQUENCY INCLUDED FUMAR ACID ESTE | |
| PT1406898E (en) | SUBSTITUTED PIPERAZINE COMPOUNDS AND ITS USE AS OXIDACAO INHIBITORS OF FATTY ACIDS | |
| ES2421556T3 (en) | Use of cardiac hormones to diagnose the risk of cardiovascular complications as a result of cardiotoxic medications | |
| ECSP024244A (en) | USE OF (Z) -2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID (4´-TRIFLUOROMETHYLPHENYL) -AMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS | |
| AR055562A1 (en) | 1,3 OXAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM. | |
| PA8552001A1 (en) | 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS | |
| NO20075209L (en) | Substituted aryl 1,4-pyrazine derivatives | |
| PA8552101A1 (en) | 6,7,8,9-TETRAHIDRO-5H-BENZOCICLOHEPTENIL ACILATED AMINES AND ITS USE AS PHARMACOS | |
| PA8551901A1 (en) | INDANIL ACILATED AMINAS AND ITS USE AS PHARMACOS | |
| SV2006000884A (en) | 6,7,8,9-TETRAHIDRO-5H-BENZOCICLOHEPTENIL ACILATED AMINES AND ITS USE AS PHARMACOS | |
| MXPA02008213A (en) | Substituted piperazine compounds. | |
| PA8683901A1 (en) | AMIDAS REPLACED WITH HETEROARILO THAT INCLUDE A SATURATED LINKER GROUP, AND ITS USE AS PHARMACEUTICAL AGENTS | |
| SE0401539D0 (en) | New compounds | |
| SE0401540D0 (en) | New compounds | |
| PA8609101A1 (en) | PIRIDO DERIVATIVES [3,4-D] PYRIMIDINE AS INHIBITORS OF METALOPROTEINASE-13 OF THE MATRIX |